Rheumatology: Current Research
Open Access
ISSN: 2161-1149 (Printed)
+44-77-2385-9429
ISSN: 2161-1149 (Printed)
+44-77-2385-9429
Clinic of Internal Medicine III, Department of Internal Medicine III with Haematology, Medical Oncol, Paracelsus Medical University, Salzburg, Austria, Cancer Cluster Salzburg, Austria
Dr. Studnicka-Benke A works at the Clinic of Internal Medicine III, Department of Internal Medicine III with Haematology, Medical Oncology, Paracelsus Medical University, Salzburg, Austria, Cancer Cluster Salzburg, Austria. Dr. Studnicka-Benke A has received several awards for their contributions to the scientific community. Dr. Studnicka-Benke A's major research interest involves Haematology, Medical Oncology.
Case Report
Good Response of Lupus Hepatitis to Mycophenolate Mofetil and Belimumab as of Lupus Exanthema to Rituximab: A Case Report
Author(s): Psenak O*, Studnicka-Benke A, Haufe H and Greil R
A 66-year-old male patient had been primarily treated for cutaneous lupus erythematosus 15 years ago. He received local corticosteroids and following systemic immunosuppressants: methylprednisolone (MP), chloroquine (removed due to retinal haemorrhage), cyclosporine A and azathioprine (both removed due to non-response). Due to polyarthralgia methotrexate as well as golimumab were started. Despite good response, both drugs had to be stopped due to development of hepatitis confirmed by liver biopsy (virus serological tests were negative).
Early after onset of a combination treatment with 1 g mycophenolate mofetil (MMF) per day orally and 10 mg/kg belimumab intravenously at weeks 0, 2, 4, followed by every 4 weeks, a marked decrease in liver enzymes could be detected. Due to insufficient response of lupus exanthema, hydroxychloroquine (HCQ) was added.
After 9 months o.. View More»
DOI:
10.35248/2161-1149.19.9.247